Read Time:11 Second
Alembic Pharmaceuticals Limited has informed the Exchange regarding ‘Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015’ that Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals Limited has acquired Utility Therapeutics Ltd. |SUBJECT: Updates
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
